Insights

Chirality in drug development: from racemic mixtures to enantiopure substances

January 19, 2025

In this Ardena Insight, we explore advanced crystallization techniques that transform racemic mixtures into enantiopure substances. These approaches ensure higher purity and targeted efficacy, playing a key role in the development of safer, more effective drugs.

With extensive expertise in drug substance development and solid state research, Ardena provides tailored solutions to support your chiral drug development needs.

Want to Learn More?

Explore our full range of services and discover how Ardena can support your drug development journey.

Resources